BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 326202)

  • 1. [Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].
    Fritz J; Grond K
    Arch Dermatol Res (1975); 1977 Apr; 258(2):121-6. PubMed ID: 326202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cellular immunity in melanomalignome (author's transl)].
    Fritz J; Grond K; Tilz GP
    Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 4. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
    Kokoschka EM; Cerni C; Micksche M
    Oncology; 1977; 34(5):229-33. PubMed ID: 917456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NK function elucidated with respect to effector cells, target cells and other immunological in vitro tests.
    Kristensen E
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):449-53. PubMed ID: 6681340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitization of lymphocyte to tumor extract detected by macrophage migration inhibition test(MIT) in patients with cervical cancer (author's transl)].
    Ohno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):919-28. PubMed ID: 7240870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of leucocyte migration by tumour-associated antigens of the colon and rectum.
    Guillou PJ; Giles GR
    Gut; 1973 Sep; 14(9):733-8. PubMed ID: 4201667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
    Isbister WH
    N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
    Lieberman R; Wybran J; Epstein W
    Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)].
    Lischka G
    Arch Dermatol Res (1975); 1975 Sep; 253(2):105-12. PubMed ID: 1190833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
    de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
    Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of cellular immunity to tumor-specific antigens of malignant melanoma in hamsters by inhibition of macrophage migration.
    Henderson WR; Fukuyama K; Epstein WL; Spitler LE
    J Invest Dermatol; 1972 Apr; 58(4):229-32. PubMed ID: 5020976
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukocyte migration inhibition by cancer patients' sera.
    Cochran AJ; Mackie RM; Ross CE; Ogg LJ; Jackson AM
    Int J Cancer; 1976 Sep; 18(3):274-81. PubMed ID: 1066319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a leucocyte adherence test with the leucocyte migration inhibition test and skin reactivity to PPD.
    Bullen AW; Losowsky MS
    Clin Exp Immunol; 1978 Mar; 31(3):408-13. PubMed ID: 350459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunological aspect of melanoma and its potential application in adjuvant therapy.
    Elias EG; Tomazic VJ
    J Surg Oncol; 1991 Dec; 48(4):220-3. PubMed ID: 1745045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of cellular immunity in melanoma by means of a modified leukocyte migration inhibition test].
    Bowszyc J; Bowszyc J; Wojnerowicz-Grajewska M; Milanowski L
    Przegl Dermatol; 1980; 67(3):319-23. PubMed ID: 6968922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.